Generali Investments Towarzystwo Funduszy Inwestycyjnych
Position in LLY — ELI LILLY & Co
CIK 2043130
WARSAW, R9
Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,811,139
+$252,129 QoQ
Shares Held
1,510
-10.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#2,579
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments Towarzystwo Funduszy Inwestycyjnych holds $8,405,860 across 8 Drug Manufacturers - General names. LLY ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
87,000 | $2,094,960 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,510 | $1,811,139 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,000 | $1,799,000 | |
| 4 | AMGN |
Amgen Inc
|
2,500 | $905,300 | |
| 5 | JNJ |
Johnson & Johnson
|
3,100 | $787,307 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,500 | $605,010 | |
| 7 | ABBV |
AbbVie Inc.
|
1,100 | $276,804 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,000 | $126,340 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,811,139 | 1,510 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,559,010 | 1,695 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,816,209 | 1,690 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,464,960 | 1,920 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,418,744 | 1,820 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,271,901 | 1,540 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,188,880 | 1,540 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||